The convergence of photonics, AI, microfluidics and live-cell analytics could offer researchers a new way to study disease biology, not merely as a series of static snapshots, but as processes unfolding in real time
The companies announced that the patent application covers a jointly developed substance related to nucleic acid pharmaceuticals
ProBioGen will leverage its proprietary HEK293 host cell line platform to drive cell line development for VarmX's Factor X program
The companies are targeting that unmet need by developing oral small molecules designed to offer improved potency, safety, bioavailability, and patient accessibility
The Bengaluru facility consolidates analytical chemistry, formulation development, pharmacognosy and clinical research in a single integrated hub
The FDA decision follows Fabhalta’s accelerated approval in August 2024 for reducing proteinuria
The new 2,000-square-meter facility will provide commercial drug substance and drug product release testing, along with stability testing services
Collaborative innovation aims to strengthen early disease monitoring, clinical decision-making, and remote respiratory care
The new test is designed to help healthcare providers identify HDV infections earlier
SkinMedica’s newly launched Regenerative Science Advisory Board brings together physicians, clinicians and skin health experts
Researchers identify patient-specific drug candidates for Sanfilippo syndrome type B, highlighting the potential of precision drug repurposing for rare diseases
The company bets on specialty portfolio, innovation as latest investor presentation highlights the company's global growth strategy
The company will present 18 oral and poster presentations at the global Alzheimer’s research meeting
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
Collaboration integrates MERCURIUS DRUG-seq technologies with Revvity’s screening portfolio, enabling scalable transcriptomic profiling for next-generation drug discovery and AI-driven research
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
The collaboration will foster joint research initiatives, scientific knowledge exchange, and innovation
Investigational once-weekly GLP-1 and amylin receptor agonist achieves up to 14.6% weight loss and significant blood sugar reductions
Subscribe To Our Newsletter & Stay Updated
